Status:
WITHDRAWN
Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis
Lead Sponsor:
Alcon Research
Conditions:
Bacterial Conjunctivitis
Eligibility:
All Genders
5+ years
Phase:
PHASE2
Brief Summary
To assess safety and efficacy of AL-15469A 0.5% /AL-6515 0.3% Ophthalmic Suspension for treatment of bacterial conjunctivitis
Eligibility Criteria
Inclusion
- Male and female patients of any race
- 5 years of age and older at the time of the Day 1 visit
- with a primary clinical diagnosis of bacterial conjunctivitis.
Exclusion
- Onset of bacterial conjunctivitis (signs and symptoms) more than 4 days
- Presence of punctal plug or punctal occlusion
- Visual Acuity worse than 20/80
- Upper respiratory infection
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01238783
Start Date
January 1 2011
Last Update
December 1 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.